CRISPR modification overcomes major hurdle to human treatments
Scientists modify CRISPR/Cas9 to treat diabetes, kidney disease, and muscular dystrophy in mice, without cutting DNA. In its five years of existence, CRISPR/Cas9 has revolutionized the field of gene editing, allowing researchers to edit DNA like a piece of text. While it’s potential is unquestionable, ethics and safety concerns have prevented CRISPR from being used to treat human diseases.
No comments:
Post a Comment